FB

Fralin Biomedical Research Institute at Virginia Tech at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Fralin Biomedical Research Institute at Virginia Tech brings 1 presentation to AMP 2026 in Seattle. Its session covers measurable residual disease detection and monitoring in solid tumours and blood cancers, using personalised tumour-informed droplet digital PCR assays in research settings.

OrganizationAMP 2026 Attendance
FB
Fralin Biomedical Research Institute at Virginia Tech
Roanoke, VA
Med centres
Biomedical research institute in Roanoke operated by Virginia Tech, with laboratories in neuroscience, cancer biology and cardiovascular disease.
Workshop
Wed, Nov 11
8:00am–8:50am
MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings
Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours.
Workshop hosted by Bio-Rad Laboratories
Tahoma 3, Level 3, Arch at 800 Pike

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Fralin Biomedical Research Institute at Virginia Tech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction